New Results
A comprehensive multicenter comparison of whole genome sequencing pipelines using a uniform tumor-normal sample pair
Ivo Buchhalter, Barbara Hutter, Tyler S. Alioto, Timothy A. Beck, Paul C. Boutros, Benedikt Brors, Adam P. Butler, Sasithorn Chotewutmontri, Robert E. Denroche, Sophia Derdak, Nicolle Diessl, Lars Feuerbach, Akihiro Fujimoto, Susanne Gröbner, Marta Gut, Nicholas J. Harding, Michael Heinold, Lawrence E. Heisler, Jonathan Hinton, Natalie Jäger, David Jones, Rolf Kabbe, Andrey Korshunov, John D. McPherson, Andrew Menzies, Hidewaki Nakagawa, Christopher Previti, Keiran Raine, Paolo Ribeca, Sabine Schmidt, Rebecca Shepherd, Lucy Stebbings, Patrick S. Tarpey, Jon W. Teague, Laurie Tonon, David A. Wheeler, Liu Xi, Takafumi N. Yamaguchi, Anne-Sophie Sertier, Stefan M. Pfister, Peter J. Campbell, Matthias Schlesner, Peter Lichter, Roland Eils, Ivo G. Gut, David T. W. Jones, on behalf of the ICGC Verification and Validation Working Group
doi: https://doi.org/10.1101/013177
Ivo Buchhalter
1Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
2Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Barbara Hutter
2Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Tyler S. Alioto
3Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, c/ Baldiri Reixac, 4-8, 08028 Barcelona, Spain
Timothy A. Beck
4Ontario Institute for Cancer Research, 661 University Ave, Suite 510, Toronto Ontario Canada M5G 0A3
Paul C. Boutros
4Ontario Institute for Cancer Research, 661 University Ave, Suite 510, Toronto Ontario Canada M5G 0A3
Benedikt Brors
2Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Adam P. Butler
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Sasithorn Chotewutmontri
6Genome and Proteome Core Facility, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Robert E. Denroche
4Ontario Institute for Cancer Research, 661 University Ave, Suite 510, Toronto Ontario Canada M5G 0A3
Sophia Derdak
3Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, c/ Baldiri Reixac, 4-8, 08028 Barcelona, Spain
Nicolle Diessl
6Genome and Proteome Core Facility, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Lars Feuerbach
2Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Akihiro Fujimoto
7RIKEN Center for Integrative Medical Sciences, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
Susanne Gröbner
8Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany
Marta Gut
3Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, c/ Baldiri Reixac, 4-8, 08028 Barcelona, Spain
Nicholas J. Harding
4Ontario Institute for Cancer Research, 661 University Ave, Suite 510, Toronto Ontario Canada M5G 0A3
Michael Heinold
2Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Lawrence E. Heisler
4Ontario Institute for Cancer Research, 661 University Ave, Suite 510, Toronto Ontario Canada M5G 0A3
Jonathan Hinton
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Natalie Jäger
1Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
David Jones
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Rolf Kabbe
1Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Andrey Korshunov
9Department of Neuropathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany
John D. McPherson
4Ontario Institute for Cancer Research, 661 University Ave, Suite 510, Toronto Ontario Canada M5G 0A3
Andrew Menzies
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Hidewaki Nakagawa
7RIKEN Center for Integrative Medical Sciences, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
Christopher Previti
6Genome and Proteome Core Facility, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Keiran Raine
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Paolo Ribeca
3Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, c/ Baldiri Reixac, 4-8, 08028 Barcelona, Spain
Sabine Schmidt
6Genome and Proteome Core Facility, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Rebecca Shepherd
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Lucy Stebbings
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Patrick S. Tarpey
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Jon W. Teague
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Laurie Tonon
10Synergie Lyon Cancer Foundation, Centre Léon Bérard, Cheney C, 28 rue Laennec, 69373 LYON Cedex 08
David A. Wheeler
11Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, U.S.A.
Liu Xi
11Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, U.S.A.
Takafumi N. Yamaguchi
4Ontario Institute for Cancer Research, 661 University Ave, Suite 510, Toronto Ontario Canada M5G 0A3
Anne-Sophie Sertier
10Synergie Lyon Cancer Foundation, Centre Léon Bérard, Cheney C, 28 rue Laennec, 69373 LYON Cedex 08
Stefan M. Pfister
8Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany
12Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Peter J. Campbell
5Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK, CB10 1SA
Matthias Schlesner
1Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Peter Lichter
13Division of Molecular Genetics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Roland Eils
1Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
14Institute of Pharmacy and Molecular Biotechnology (IPMB), University of Heidelberg, Heidelberg, 69120, Germany
15Bioquant Center, University of Heidelberg, Im Neuenheimer Feld 267, Heidelberg, 69120, Germany
Ivo G. Gut
3Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, c/ Baldiri Reixac, 4-8, 08028 Barcelona, Spain
David T. W. Jones
8Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany
Article usage
Posted December 24, 2014.
A comprehensive multicenter comparison of whole genome sequencing pipelines using a uniform tumor-normal sample pair
Ivo Buchhalter, Barbara Hutter, Tyler S. Alioto, Timothy A. Beck, Paul C. Boutros, Benedikt Brors, Adam P. Butler, Sasithorn Chotewutmontri, Robert E. Denroche, Sophia Derdak, Nicolle Diessl, Lars Feuerbach, Akihiro Fujimoto, Susanne Gröbner, Marta Gut, Nicholas J. Harding, Michael Heinold, Lawrence E. Heisler, Jonathan Hinton, Natalie Jäger, David Jones, Rolf Kabbe, Andrey Korshunov, John D. McPherson, Andrew Menzies, Hidewaki Nakagawa, Christopher Previti, Keiran Raine, Paolo Ribeca, Sabine Schmidt, Rebecca Shepherd, Lucy Stebbings, Patrick S. Tarpey, Jon W. Teague, Laurie Tonon, David A. Wheeler, Liu Xi, Takafumi N. Yamaguchi, Anne-Sophie Sertier, Stefan M. Pfister, Peter J. Campbell, Matthias Schlesner, Peter Lichter, Roland Eils, Ivo G. Gut, David T. W. Jones, on behalf of the ICGC Verification and Validation Working Group
bioRxiv 013177; doi: https://doi.org/10.1101/013177
A comprehensive multicenter comparison of whole genome sequencing pipelines using a uniform tumor-normal sample pair
Ivo Buchhalter, Barbara Hutter, Tyler S. Alioto, Timothy A. Beck, Paul C. Boutros, Benedikt Brors, Adam P. Butler, Sasithorn Chotewutmontri, Robert E. Denroche, Sophia Derdak, Nicolle Diessl, Lars Feuerbach, Akihiro Fujimoto, Susanne Gröbner, Marta Gut, Nicholas J. Harding, Michael Heinold, Lawrence E. Heisler, Jonathan Hinton, Natalie Jäger, David Jones, Rolf Kabbe, Andrey Korshunov, John D. McPherson, Andrew Menzies, Hidewaki Nakagawa, Christopher Previti, Keiran Raine, Paolo Ribeca, Sabine Schmidt, Rebecca Shepherd, Lucy Stebbings, Patrick S. Tarpey, Jon W. Teague, Laurie Tonon, David A. Wheeler, Liu Xi, Takafumi N. Yamaguchi, Anne-Sophie Sertier, Stefan M. Pfister, Peter J. Campbell, Matthias Schlesner, Peter Lichter, Roland Eils, Ivo G. Gut, David T. W. Jones, on behalf of the ICGC Verification and Validation Working Group
bioRxiv 013177; doi: https://doi.org/10.1101/013177
Subject Area
Subject Areas
- Biochemistry (11562)
- Bioengineering (8622)
- Bioinformatics (28865)
- Biophysics (14793)
- Cancer Biology (11921)
- Cell Biology (17165)
- Clinical Trials (138)
- Developmental Biology (9302)
- Ecology (14019)
- Epidemiology (2067)
- Evolutionary Biology (18128)
- Genetics (12145)
- Genomics (16615)
- Immunology (11706)
- Microbiology (27690)
- Molecular Biology (11386)
- Neuroscience (60092)
- Paleontology (447)
- Pathology (1847)
- Pharmacology and Toxicology (3183)
- Physiology (4878)
- Plant Biology (10276)
- Synthetic Biology (2849)
- Systems Biology (7289)
- Zoology (1618)